Report calls for free market-based drug policyGovernment intervention in prescription drug markets provides little benefit for Canadian consumers: Fraser Institute report Nurses extract health lessons from The Wizard of Oz New drug delivery system: the nanosponge? Low-dose combo therapy fends off diabetes Canadian trial of rosiglitazone-metformin pill not powered for adverse cardiovascular events Don’t forget fibrates A major meta-analysis of fibrate drugs has shown they modestly reduce the risk of major cardiovascular events, mainly through prevention of coronary artery disease and the need for revascularization. TD payment suggestions ‘interesting’ OMA says Bank recommends Ontario end fee-for-service model Hybrid therapy tops for H. pylori infection Two-week combined strategy achieves superior eradication rates New protease inhibitor showing promise for hepatitis C Early study suggests experimental drug telaprevir offers option for patients who have not responded to standard treatment How much do adverse events cost? Focused research to determine economics of patient safety Three of 5 nurses in Florida are leaving the state's work force First Previous 393 394 395 396 397 Next Last
